Gordon, Kenneth, Kim Papp, Melinda Gooderham, Akimichi Morita, Peter Foley, Diamant Tha?i, Sundeep Kundu, Renata Kisa, Lan Wei, and Subhashis Banergee. “BMS-986165, an Oral, Selective Tyrosine Kinase 2 (TYK2) Inhibitor: Evaluation of Changes in Laboratory Parameters in Response to Treatment in a Phase 2 Trial in Psoriasis Patients”. SKIN The Journal of Cutaneous Medicine 4, no. 5 (September 2, 2020): s28. Accessed June 30, 2022. https://www.jofskin.org/index.php/skin/article/view/977.